New warning on singulair's label

  • Thread starter Thread starter JennaM
  • Start date Start date
J

JennaM

Guest
The following warning has been added to the "Precautions" section of Singulair's label:

"Neuropsychiatric Events

Neuropsychiatric events have been reported in adult, adolescent, and
pediatric patients taking SINGULAIR. Post-marketing reports with SINGULAIR use include agitation, aggressive behavior or hostility, anxiousness, depression, dream abnormalities, hallucinations, insomnia, irritability, restlessness, somnarabulism, suicidal thinking and behavior (including suicide), and tremor. The clinical details of some post-marketing reports involving SINGULAIR appear consistent with a drug-induced effect. Patients and prescribers should be alert for neuropsychiatric events.

Patients should be instructed to notify their prescriber if these changes occur. Prescribers should carefully evaluate the risks and benefits of continuing treatment with SINGULAIR if such events occur."

(Note: somnarabulism = sleepwalking)

Pharmacy printouts may not include this new information, or a complete list of side effects, because they are not regulated by the FDA. These printouts do advise patients to report adverse reactions to the FDA.
 
Since I stopped taking Singular my anxiety nearly disappeared. I really do think this drug does something to your brain!

I also had a lot of headaches while taking it that resolved after I stopped taking it.
 
I was on Singulair for two years and never noticed any side effects (or never thought my issues were related to the med). I went off the drug for six months and just started it again. I have noticed that I feel like I am in a mental fog. I have also had a mild headache. Hence, I think I am kicking it to the curb and sticking with Allegra.

My allergist suggested I get back on the Singulair because of chronic sinus infections. My primary care doc, however, thinks Singulair is about effective as a "Tic-Tac." :)
 
Back
Top